These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15065691)

  • 1. Non-pharmacological management of type 2 diabetes.
    Buysschaert M; Hermans MP
    Acta Clin Belg; 2004; 59(1):14-9. PubMed ID: 15065691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in treating type 2 diabetes.
    Hollander PA
    Postgrad Med; 2000 May; 107(6 Suppl Key):4-10. PubMed ID: 19667504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
    Blonde L; Dempster J; Gallivan JM; Warren-Boulton E
    J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient management strategies in type 2 diabetes: current practices and future considerations.
    Blonde L
    J Manag Care Pharm; 2005 Aug; 11(6 Suppl B):S12-8. PubMed ID: 23570225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing cardiovascular risk in patients with type 2 diabetes: focus on primary care.
    Stolar M
    Am J Med Sci; 2011 Feb; 341(2):132-40. PubMed ID: 20818229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?
    Rimareix F; Bauduceau B
    Ann Endocrinol (Paris); 2013 Jul; 74(3):207-10. PubMed ID: 23747137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex dietary measures and pharmacotherapy for metabolic syndrome].
    Pfeiffer AF; Kohl A
    Internist (Berl); 2007 Feb; 48(2):164-72. PubMed ID: 17268786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
    Collins FM
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S460-71. PubMed ID: 12408409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stepwise approach to the management of type 2 diabetes.
    Warren RE
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach to type 2 diabetes.
    Conlon PC
    Nurs Clin North Am; 2001 Jun; 36(2):193-202, v. PubMed ID: 11382559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices in the care of type 2 diabetes: integrating clinical needs with medical policy and practice.
    Bunn WB
    Am J Manag Care; 2009 Sep; 15(9 Suppl):S263-8. PubMed ID: 19817515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic approach to the management of the Type II diabetic patient: case presentation.
    Coleman LT
    Pharm Pract Manag Q; 1997 Oct; 17(3):65-75. PubMed ID: 10173312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontiers in the management of type 2 diabetes.
    Mudaliar S
    Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
    Nadeau DA
    Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF
    Diabetes Educ; 2008; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
    Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
    Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.